Investing RAD Granted US FDA Fast Track for RAD101 Metastases Imaging June 11, 2025 Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Granted US FDA Fast Track for RAD101 Metastases Imaging Download the PDF here. This post appeared first on investingnews.com 0 Prev Post Rapid Increases Land Holding by 26 X June 11, 2025 Next Post Hyundai Builds Rare Earths Stockpile to Offset Supply Risks June 11, 2025 Related Posts Blue Sky Hosts Community and Stakeholder Water Sampling Event at the Ivana Uranium-Vanadium Project, Argentina June 13, 2025 Blue Sky Uranium Closes 1st Tranche & Increases Oversubscribed Non-Brokered Private Placement June 13, 2025 GMV Minerals Inc. Extends Exclusive Option to Acquire Mexican Hat Mining Claims – Commissions Updated Preliminary Economic Assessment June 13, 2025
Blue Sky Hosts Community and Stakeholder Water Sampling Event at the Ivana Uranium-Vanadium Project, Argentina June 13, 2025
Blue Sky Uranium Closes 1st Tranche & Increases Oversubscribed Non-Brokered Private Placement June 13, 2025
GMV Minerals Inc. Extends Exclusive Option to Acquire Mexican Hat Mining Claims – Commissions Updated Preliminary Economic Assessment June 13, 2025
